Skip to content
value.today

Limber Health, Inc.

🇺🇸 Rockville, Maryland, USATechnologyFounded 2019

Formerly Stry, Inc.

Total raised
$16 M
1 round on record
Latest round
$16 M
Apr 2022
First round on record
Apr 2022
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Limber Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2022$16 MNo. 1$10 to $50 million

Limber Health, Inc.: Raise no. 1, Apr 2022

Investors in this round

19 investors had bought by the notice of May 31, 2024: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $16 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Included is preferred stock issued in this offering, and the underlying common stock issuable upon conversion of such preferred stock.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael Gruner · Executive Officer, Director
  • Nirav Modi · Executive Officer
  • Ramon Castro · Executive Officer
  • Blake Patton · Director
  • Emir Sandhu · Director
  • Marc Gruner · Director
  • Rick Gawenda · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total offering amount and total amount sold includes the issue price of previously issued convertible securities that were converted into preferred stock in this offering.”
  • On the use of proceeds: “Proceeds will be used for general corporate purposes including payment of salaries and other work-related compensation to officers and other employees and consultants.”

Signed by Michael Gruner, President and Chief Executive Officer. Newest notice filed May 31, 2024 (2 amendments). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Limber Health, Inc. chose not to state its revenue in its newest notice of a funding round (May 2024).

    SEC Form D · May 2024

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · May 2024

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Limber Health, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Limber Health, Inc.
NameRoleNamed in
Michael GrunerExecutive officerMay 2024
Nirav ModiExecutive officerMay 2024
Ramon CastroExecutive officerMay 2024
Marc GrunerExecutive officerOct 2022
Blake PattonDirectorMay 2024
Emir SandhuDirectorMay 2024
Marc GrunerDirectorMay 2024
Michael GrunerDirectorMay 2024
Rick GawendaDirectorMay 2024
Lloyd MandellDirectorApr 2024
Ankit ChadhaDirectorOct 2022